Exclusive Vertical in CDSCO will check 'Garage Manufacturing': MTaI

Image
ANI
Last Updated : Apr 29 2019 | 7:40 PM IST

Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies having a large footprint in manufacturing, R & D and healthcare training in India, today said that creation of a separate vertical in Central Drugs Standard Control Organisation (CDSCO) exclusively to govern medical devices will check 'garage manufacturing'.

"Capacity building is always a good initiative and has been long overdue. Regulators should build capacity and capability to prevent inferior products from entering the market which was happening through a large number of unregistered garage manufacturing in India, particularly in orthopaedic industry", said Kaustav Banerjee, Director, MTaI.

"Global innovators are not just operating in India but in several developed countries across the globe and they follow global regulation and are accountable; these globally accepted standards of quality are also complied by several domestic manufacturers, which make exports from India acceptable in global markets. A separate vertical in CDSCO, as proposed by DTAB, will curb the menace of unregulated garage manufacturing," he added.

The Drugs Technical Advisory Board (DTAB) has proposed creation of a vertical in CDSCO specifically for medical devices to enable the latter regulate all medical devices sold in the country in phases. As per the proposal, CDSCO will hire 754 officers for the vertical.

"The proposal of DTAB to have a separate vertical in terms of manpower and infrastructure in CDSCO for medical devices is welcome. It is reflective of the understanding that new categories of skill-set are required to regulate this sector. The fact that this vertical will be under the CDSCO, sensitively uses the umbrella of the body which has the maximum expertise and experience in governing the medical device universe", said Pavan Choudary, MTaI Chairman and Director General.

"As new devices are coming under regulation in line with government's objective of ensuring patient safety, it will be great if the recruitment begins soon so that this additional workload is efficiently handled", Pavan concluded.

This content is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 29 2019 | 7:30 PM IST

Next Story